Does every prostate cancer need surgery?

No. Depending on risk and patient health, surveillance, surgery, radiation, systemic treatment, or other strategies may be considered.

What is reviewed in a second opinion?

PSA, MRI, biopsy, pathology, stage, proposed options, and patient priorities can all be reviewed.

What information defines the risk level?

Assessment combines PSA and its trend, biopsy grade and volume, MRI, clinical stage, general health, and additional studies when indicated.

What should I bring if I already had a biopsy?

Bring the full report, slides or blocks if available, MRI files and report, PSA history, and any prior treatment recommendation.

Illustrative image

Urologic oncology

Prostate cancer: decide with clarity.

Review PSA, MRI, biopsy, grade, and extent before discussing a strategy aligned with risk and patient priorities.

An altered PSA does not confirm cancer, and a cancer diagnosis does not lead to one universal option. Decisions integrate pathology, imaging, stage, overall health, life expectancy, and preferences around cancer control and quality of life.

Request an evaluation

Advanced specialist care

Common reasons for consultation

Altered PSA or exam

Interpret the trend, clinical context, and potential next studies.

Positive biopsy

Review grade, tumor volume, imaging, and extent.

Second opinion

Responsibly compare surveillance, surgery, radiation, and other alternatives.

10+ years

of clinical and surgical experience

7,000+

cases treated

International training

Argentina, Spain, and the United Kingdom

Educational video

Prostate cancer: the value of early detection.

Dr. Carlos A. Brugiati explains why every case should receive timely, individualized evaluation.

Educational content. It does not replace medical evaluation or confirm a diagnosis.

Structured evaluation

The diagnostic pathway

Each step answers a different question before treatment is selected.

Confirm information

PSA, examination, MRI, biopsy, and pathology-report quality are reviewed.

Define risk

Grade, stage, volume, and staging studies help classify the case.

Align priorities

Age, health, urinary and sexual function, and preferences are part of the decision.

Plan follow-up

Every strategy requires monitoring, including active surveillance.

Informed decisions

Options that may be discussed

The appropriate path depends on risk and may involve a multidisciplinary team.

Active surveillance

Structured monitoring for selected lower-risk tumors.

Surgery

Open, laparoscopic, or robot-assisted radical prostatectomy according to case and availability.

Radiation therapy

External or internal approaches considered with radiation oncology.

Systemic therapies

Hormonal or other treatments when stage and biology require them.

Prepare for your visit

Useful records

PSA history and trend
MRI report and image files
Biopsy report and slides, if available
Staging studies and prior recommendation

Explore related pathways

Stone Center HoLEP Center Focal therapy Prostate biopsy Second opinion

Safety notice

This page does not confirm a diagnosis or recommend a treatment. Heavy bleeding, inability to urinate, new severe pain, or rapid deterioration require timely care.

Frequently asked questions

Answers to prepare your next step.

No. PSA may change because of benign enlargement, inflammation, infection, procedures, and other factors.

Medical reference sources

Educational content remains reviewable. Guidelines support the conversation but do not replace individual clinical judgment.

National Cancer Institute · Prostate cancer National Cancer Institute · Prostate cancer treatment

The information on this page does not replace a medical consultation. If you have blood in your urine, urinary retention, fever, severe pain, or an elevated PSA, request an evaluation with a urologist.